                         SEQUENCE LISTING

<110>  Mao, Chuanbin
       Cao, Binrui
 
<120>  PHAGES FOR BIOMARKER CAPTURE AND METHODS OF USE

<130>  820233.02335

<150>  62/143,450
<151>  2015-04-06

<160>  17    

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  artificial sequence

<400>  1

Pro Thr Tyr Ser Leu Val Pro Arg Leu Ala Thr Gln Pro Phe Lys 
1               5                   10                  15  


<210>  2
<211>  15
<212>  PRT
<213>  artificial sequence

<400>  2

Thr Trp Val Ala Ser Ala Leu Lys Asn Leu Leu Tyr Ala Cys Pro 
1               5                   10                  15  


<210>  3
<211>  15
<212>  PRT
<213>  artificial sequence

<400>  3

Gln Leu Pro Ser Ser Thr Pro Leu Tyr Ala Thr Thr Trp Gln Pro 
1               5                   10                  15  


<210>  4
<211>  15
<212>  PRT
<213>  artificial sequence

<400>  4

Thr Val Ser Asp Glu Val Arg Leu Leu Arg Leu Pro Ser Thr Ala 
1               5                   10                  15  


<210>  5
<211>  15
<212>  PRT
<213>  artificial sequence

<400>  5

Pro Ser Ala Thr Glu Arg Leu Pro Ala Gln Ser His Pro Glu Gly 
1               5                   10                  15  


<210>  6
<211>  15
<212>  PRT
<213>  artificial sequence

<400>  6

Pro Phe Ile Ser Tyr Gly Ala Gln Thr Pro Leu Leu Pro Val Phe 
1               5                   10                  15  


<210>  7
<211>  15
<212>  PRT
<213>  artificial sequence

<400>  7

Ile Arg Gln Thr Arg Ser Arg Thr Arg Leu Ser Arg Trp Ala Ser 
1               5                   10                  15  


<210>  8
<211>  15
<212>  PRT
<213>  artificial sequence

<400>  8

Leu Arg Thr Ser Pro Ser Lys Gln Arg Asp His Leu Thr Ser Pro 
1               5                   10                  15  


<210>  9
<211>  15
<212>  PRT
<213>  artificial sequence

<400>  9

Leu Ala Leu Ser Pro Gln Ser Trp Pro Gly Pro Ala Asn Ser Ala 
1               5                   10                  15  


<210>  10
<211>  15
<212>  PRT
<213>  artificial sequence

<400>  10

Thr Pro Pro Ser Ser Ser Leu Val Val Leu Gln Ser Lys Ala Thr 
1               5                   10                  15  


<210>  11
<211>  5
<212>  PRT
<213>  artificial sequence

<400>  11

Val Lys Tyr Thr Ser 
1               5   


<210>  12
<211>  10
<212>  PRT
<213>  artificial sequence

<400>  12

Ser Gln Ala Met Asp Asp Leu Met Leu Ser 
1               5                   10  


<210>  13
<211>  9
<212>  PRT
<213>  artificial sequence

<400>  13

Cys Leu Asp Gly Gly Gly Lys Gly Cys 
1               5                   


<210>  14
<211>  10
<212>  PRT
<213>  artificial sequence

<400>  14

Arg Gly Asp Leu Ala Thr Leu Arg Gln Leu 
1               5                   10  


<210>  15
<211>  21
<212>  DNA
<213>  artificial sequence

<400>  15
tcgtcaaata tacttctact g                                                 21


<210>  16
<211>  21
<212>  DNA
<213>  artificial sequence

<400>  16
tagaagtata tttgacgacg t                                                 21


<210>  17
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  consensus sequence


<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Thr or Ser

<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  Ser or Thr

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  Leu, Val, or Ile

<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  Leu, Val, or Ile

<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  Arg or Lys

<220>
<221>  misc_feature
<222>  (9)..(9)
<223>  Leu, Val, or Ile

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  Thr or Ser

<220>
<221>  misc_feature
<222>  (12)..(12)
<223>  Gln or Asn

<220>
<221>  misc_feature
<222>  (15)..(15)
<223>  Lys or Arg

<400>  17

Pro Xaa Tyr Xaa Xaa Xaa Pro Xaa Xaa Ala Xaa Xaa Pro Phe Xaa 
1               5                   10                  15  


